Skip to content

Renasant RNST Cash & Equivalents

Cash & Equivalents at other companies

Eastern Bankshares, Inc. logo
Eastern Bankshares, Inc.EBC
$331.56M-10.1%
Old National Bancorp logo
Old National BancorpONB
$1.75B+41.5%
UBS
United BanksharesUBSI
$2.31B-11.7%
Community Financial System logo
Community Financial SystemCBU
$572.17M+10.5%
F.N.B. Corporation logo
F.N.B. CorporationFNB
$2.66B+8.8%
HOM
Home BancSharesHOMB
$1.11B-14.2%

Other financials

Income statement

See full
Revenue$273.8M+60.5%
Net income$88.2M+113%
EPS (diluted)$0.94+44.6%

Balance sheet

See full
Total debt$806.2M+48.9%
Total equity$3.9B+41.8%
Total assets$27.1B+48.4%

Cash flow

See full
Operating cash flow$100.1M+99.7%
CapEx$6.3M+31.3%
Free cash flow$93.7M+107%

Valuation

See full
Market cap$3.85B+55.1%
Enterprise value$3.44B+82.5%
P/E16.9×+4.3×
P/S3.5×+0.1×

Profitability

See full
Net margin20.9%-6.4pp
FCF margin32.7%-18.2pp

Returns & leverage

See full
Return on equity6.9%-0.9pp
Debt / equity0.2×0.0×

Where this comes from

Reported directly by Renasant in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Renasant’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Renasant's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Renasant's cash & equivalents?
Renasant (RNST) reported cash & equivalents of $1.22B in Q1 2026.
How has Renasant's cash & equivalents changed year-over-year?
Renasant's cash & equivalents increased by 11.5% year-over-year, from $1.09B to $1.22B.
What is the long-term trend for Renasant's cash & equivalents?
Over 5 years (2020 to 2025), Renasant's cash & equivalents has grown at a 11.1% compound annual growth rate (CAGR), from $633.2M to $1.07B.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.